UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells

Journal of translational medicine, 2014-04, Vol.12 (1), p.100-100, Article 100

2014

Volltextzugriff (PDF)

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer

Oncoimmunology, 2018-12, Vol.7 (12), p.e1466766-e1466766

2018

Volltextzugriff (PDF)

Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine

Journal for immunotherapy of cancer, 2016-05, Vol.4 (1), p.25-25, Article 25

2016

Volltextzugriff (PDF)

Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs

Oncoimmunology, 2012-09, Vol.1 (6), p.976-978

2012

Volltextzugriff (PDF)

148 Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A168-A168

2023

Volltextzugriff (PDF)

680 Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A771-A771

2023

Volltextzugriff (PDF)

TAF1 Histone Acetyltransferase Activity in Sp1 Activation of the Cyclin D1 Promoter

Molecular and Cellular Biology, 2005-05, Vol.25 (10), p.4321-4332

2005

Volltextzugriff (PDF)

443 An immunotherapy trio in advanced HNSCC for coordinated B and T cell antigen response

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A469-A469

2020

Volltextzugriff (PDF)

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

Journal for immunotherapy of cancer, 2017-12, Vol.5 (1), p.103-103, Article 103

2017

Volltextzugriff (PDF)

TBP2, a Vertebrate-Specific Member of the TBP Family, Is Required in Embryonic Development of Zebrafish

Current biology, 2004-04, Vol.14 (7), p.593-598

2004

Volltextzugriff (PDF)

SRC Proximal and Core Promoter Elements Dictate TAF1 Dependence and Transcriptional Repression by Histone Deacetylase Inhibitors

Molecular and Cellular Biology, 2004-03, Vol.24 (6), p.2296-2307

2004

Volltextzugriff (PDF)

Transcription factor IID recruitment and Sp1 activation. Dual function of TAF1 in cyclin D1 transcription

The Journal of biological chemistry, 2003-04, Vol.278 (15), p.12992-13002

2003

Volltextzugriff (PDF)

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies

Journal for immunotherapy of cancer, 2014-11, Vol.2 (S3), p.P247-P247, Article P247

2014

Volltextzugriff (PDF)

Pitx2-dependent Occupancy by Histone Deacetylases Is Associated with T-box Gene Regulation in Mammalian Abdominal Tissue

The Journal of biological chemistry, 2010-04, Vol.285 (15), p.11129-11142

2010

Volltextzugriff (PDF)

Abstract 38: Development of a DC-targeted microvesicle vaccine to intercept the progression of oral preneoplasia to cancer

Clinical cancer research, 2017-12, Vol.23 (23_Supplement), p.38-38

2017

Volltextzugriff (PDF)

113 Uncovering the dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC): relevance for universal cancer vaccines, immunological monitoring and TIL therapy

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A125-A125

2022

Volltextzugriff (PDF)

Abstract CT112: An off-the-shelf multivalent vaccine containing cancer’s dark matter, DPV-001, combined with PD-1 +/- GITR in head & neck cancer: safety, efficacy, and immunodynamics from the phase 1 GITRVax trial

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT112-CT112

2024

Volltextzugriff (PDF)

T cell population expansion in response to allogeneic cancer vaccine alone (DPV-001) or with granulocyte-macrophage colony-stimulating factor (GM-CSF) or imiquimod (I) for definitively-treated stage III NSCLC patients (pts)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e14639-e14639

2017

Volltextzugriff (PDF)

Abstract CT123: Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT123-CT123

2023

Volltextzugriff (PDF)

Transcription Factor IID Recruitment and Sp1 Activation

The Journal of biological chemistry, 2003-04, Vol.278 (15), p.12992-13002

2003

Volltextzugriff (PDF)

P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC: Topic: Multimodality Treatment

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S873-S873

2017

Volltextzugriff (PDF)

P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S873

2017

Volltextzugriff (PDF)

Autophagosome-enriched cancer vaccine strategy provides a novel non-genetic method to engineer leukocytes to express molecules that may augment cancer immunotherapy. (P4252)

The Journal of immunology (1950), 2013-05, Vol.190 (1_Supplement), p.47-47.14

2013

Volltextzugriff (PDF)

Abstract CT502: Preliminary immunological monitoring of first-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.CT502-CT502

2022

Volltextzugriff (PDF)

Prediction of regulatory networks in mouse abdominal wall

Gene, 2010-12, Vol.469 (1), p.1-8

2010

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(37)
Dissertationen
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells

Autophagosome-based strategy to monitor apparent tumor-specific CD8 T cells in patients with prostate cancer

Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine

Autophagy-assisted antigen cross-presentation: Autophagosome as the argo of shared tumor-specific antigens and DAMPs

148 Characterizing cancer’s dark matter, short-lived proteins, and defective ribosomal products, presented by cancer and contained in the DPV-001 cancer vaccine

680 Multi-parametric assessment of the immune response to a trio immunotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma

TAF1 Histone Acetyltransferase Activity in Sp1 Activation of the Cyclin D1 Promoter

443 An immunotherapy trio in advanced HNSCC for coordinated B and T cell antigen response

A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer

TBP2, a Vertebrate-Specific Member of the TBP Family, Is Required in Embryonic Development of Zebrafish

SRC Proximal and Core Promoter Elements Dictate TAF1 Dependence and Transcriptional Repression by Histone Deacetylase Inhibitors

Transcription factor IID recruitment and Sp1 activation. Dual function of TAF1 in cyclin D1 transcription

Characterizing the immunoprofile and endogenous immune response to squamous cell carcinomas of the head and neck to guide development of effective immunotherapy strategies

Pitx2-dependent Occupancy by Histone Deacetylases Is Associated with T-box Gene Regulation in Mammalian Abdominal Tissue

Abstract 38: Development of a DC-targeted microvesicle vaccine to intercept the progression of oral preneoplasia to cancer

113 Uncovering the dark immunopeptidome of head and neck squamous cell carcinoma (HNSCC): relevance for universal cancer vaccines, immunological monitoring and TIL therapy

Abstract CT112: An off-the-shelf multivalent vaccine containing cancer’s dark matter, DPV-001, combined with PD-1 +/- GITR in head & neck cancer: safety, efficacy, and immunodynamics from the phase 1 GITRVax trial

T cell population expansion in response to allogeneic cancer vaccine alone (DPV-001) or with granulocyte-macrophage colony-stimulating factor (GM-CSF) or imiquimod (I) for definitively-treated stage III NSCLC patients (pts)

Abstract CT123: Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma

Transcription Factor IID Recruitment and Sp1 Activation

P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC: Topic: Multimodality Treatment

P2.02-043 Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC

Autophagosome-enriched cancer vaccine strategy provides a novel non-genetic method to engineer leukocytes to express molecules that may augment cancer immunotherapy. (P4252)

Abstract CT502: Preliminary immunological monitoring of first-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma

Prediction of regulatory networks in mouse abdominal wall

Suchergebnisse filtern